North America Addictions Therapeutics Market Developments and Forecast by 2027
North America Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type (Nicotine Addiction Treatment, Alcohol Addiction Treatment, Opioid Addiction Treatment, Other Substance Addiction Treatment); Drug Type (Varenicline, Bupropion, Nicotine Replacement Products, Buprenorphine, Naltrexone, Disulfiram, Others); Treatment Center (Outpatient Treatment Center, Residential Treatment Center, Inpatient Treatment Center); Distribution Channel (Hospitals, Medical Stores, Others) and Country
- Report Date : Dec 2020
- Report Code : TIPRE00017280
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 94
The North America Addictions Therapeutics market is expected to reach US$ 6,102.31 million by 2027 from US$ 3,715.23 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027.
The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.
Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individual’s brain, behavior, and metabolic processes leading to an inability to control. Non-medical use and abuse of prescription drugs are becoming severe issues worldwide. Addiction to abusive substances is responsible for the death of millions of people across the world. According to the National Institute on Drug Abuse (NIDA) estimates, ~21 million people across the world had at least one addiction in 2019, out of which only 10% received treatment for the same. The Addiction Center reports state that the number of people undertaking treatments for addictions has increased in recent years. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the North America addiction therapeutics market in the coming years. Similarly, awareness campaigns and government efforts to counteract drug abuse and promote medication for all sorts of addiction treatments would fuel the market growth during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
North America Addictions Therapeutics Market: Strategic Insights
Market Size Value in US$ 3,715.23 Million in 2019 Market Size Value by US$ 6,102.31 Million by 2027 Growth rate CAGR of 6.5% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
North America Addictions Therapeutics Market: Strategic Insights
| Market Size Value in | US$ 3,715.23 Million in 2019 |
| Market Size Value by | US$ 6,102.31 Million by 2027 |
| Growth rate | CAGR of 6.5% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The COVID-19 pandemic is hindering the North America addictions therapeutics market. Due to the outbreak of disease, healthcare industries have been affected severely, considering the economic conditions in the current situation. Moreover, the traditional difficulties regarding treatment access and adherence for the population suffering from addictions will worsen during the pandemic, therefore aggravating their condition.
North America Addictions Therapeutics Market Report Scope
North America Addictions Therapeutics Market Segmentation
By Treatment Type
- Opioid Addiction Treatment
- Alcohol Addiction Treatment
- Nicotine Addiction Treatment
- Other Substance Addiction Treatment
By Drug Type
- Buprenorphine
- Naltrexone
- Bupropion
- Disulfiram
- Nicotine Replacement Products
- Varenicline
- Others
By Treatment Center
- Inpatient Treatment Center
- Residential Treatment Center
- Outpatient Treatment Center
By Distribution Channel
- Hospital Pharmacies
- Medical stores
- Others
By Country
- United States
- Canada
- Mexico
Company Profiles
- Indivior PLC
- Pfizer Inc
- GlaxoSmithKline plc
- Bausch Health Companies Inc
- Cipla Inc.
- Orexo AB
- Purdue Pharma L.P
- Alvogen
- Camurus AB
- Hikma Pharmaceuticals PLC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment Type, Drug Type, Treatment Center, Distribution Channel and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Addictions Therapeutics Market – By Treatment Type
1.3.2 North America Addictions Therapeutics Market – By Drug Type
1.3.3 North America Addictions Therapeutics Market – By Treatment Center
1.3.4 North America Addictions Therapeutics Market – By Distribution Channel
1.3.5 North America Addictions Therapeutics Market – By Country
2. Addictions Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Addiction Therapeutics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
5. Addiction Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Addiction Among General Populace
5.1.2 Conduction of Awareness Campaigns
5.2 Market Restraint
5.2.1 Steeping Costs of Drug Development
5.3 Market Opportunity
5.3.1 Rising Demand for R&D from Contract Organizations
5.4 Future Trend
5.4.1 Consistent Launch of Therapeutics
5.5 Impact Analysis
6. Addiction Therapeutics Market – North America Analysis
6.1 North America Addictions Therapeutics Marker Revenue Forecast and Analysis
7. Addictions Therapeutics Market– Treatment Type
7.1 Overview
7.2 Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)
7.3 Nicotine Addiction Treatment
7.3.1 Overview
7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
7.4 Alcohol Addiction Treatment
7.4.1 Overview
7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
7.5 Opioid Addiction Treatment
7.5.1 Overview
7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
7.6 Other Substance Addiction Treatment
7.6.1 Overview
7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8. Addictions Therapeutics Market– Drug Type
8.1 Overview
8.2 Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)
8.3 Varenicline
8.3.1 Overview
8.3.1.1 Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.4 Bupropion
8.4.1 Overview
8.4.1.1 Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.5 Nicotine Replacement Products
8.5.1 Overview
8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.6 Buprenorphine
8.6.1 Overview
8.6.1.1 Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.7 Naltrexone
8.7.1 Overview
8.7.1.1 Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.8 Disulfiram
8.8.1 Overview
8.8.1.1 Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
8.9 Others
8.9.1 Overview
8.9.1.1 Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
9. Addictions Therapeutics Market– Treatment Center
9.1 Overview
9.2 Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)
9.3 Outpatient Treatment Center
9.3.1 Overview
9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
9.4 Residential Treatment Center
9.4.1 Overview
9.4.1.1 Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
9.5 Inpatient Treatment Center
9.5.1 Overview
9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
10. Addictions Therapeutics Market– Distribution Channel
10.1 Overview
10.2 Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
10.4 Medical Stores
10.4.1 Overview
10.4.1.1 Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
10.5 Others
10.5.1 Overview
10.5.1.1 Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
11. Addiction Therapeutics Market Analysis and Forecasts To 2027 – North America Analysis
11.1 North America: Addiction Therapeutics Market
11.1.1 Overview
11.1.2 North America: Addiction Therapeutics Market, - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)
11.1.4 North America: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
11.1.5 North America: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
11.1.6 North America: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)
11.1.8 US: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 US: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 US: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 US: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.9 Canada: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Canada: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Canada: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Canada: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11.1.10 Mexico: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Mexico: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Mexico: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Mexico: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on North America Addiction Therapeutics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1 Indivior PLC
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bausch Health Companies Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Cipla Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Orexo AB
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Purdue Pharma L.P.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Alvogen
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Camurus AB
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Hikma Pharmaceuticals PLC
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. US: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Glossary of Terms, Medical Adhesive and Sealants Market
LIST OF FIGURES
Figure 1. Addictions Therapeutics Market Segmentation
Figure 2. Addictions Therapeutics Market – By Geography
Figure 3. Addictions Therapeutics Market Overview
Figure 4. Nicotine Addiction Treatment Segment Held Largest Share of Addictions Therapeutics Market
Figure 5. Addictions Therapeutics Market, by Geography (US$ Million)
Figure 6. North America Addictions Therapeutics Market – Leading Country Markets (US$ Million)
Figure 7. North America PEST Analysis
Figure 8. Addiction Therapeutics Market Impact Analysis of Drivers and Restraint
Figure 9. North America Addictions Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027
Figure 10. Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)
Figure 11. Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 12. Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 13. Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 14. Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 15. Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)
Figure 16. Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 17. Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 18. Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 19. Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 20. Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 23. Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)
Figure 24. Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 25. Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)
Figure 28. Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)
Figure 31. North America: Addiction Therapeutics Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America: Addiction Therapeutics Market, Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 34. US: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Market
- Indivior PLC
- Pfizer Inc
- GlaxoSmithKline plc
- Bausch Health Companies Inc
- Cipla Inc.
- Orexo AB
- Purdue Pharma L.P
- Alvogen
- Camurus AB
- Hikma Pharmaceuticals PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For